ALS Limited Logo

ALS Limited

ALQ.AX

(2.2)
Stock Price

13,67 AUD

15.2% ROA

30.34% ROE

20.71x PER

Market Cap.

6.037.574.960,00 AUD

105.95% DER

3.13% Yield

11.78% NPM

ALS Limited Stock Analysis

ALS Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

ALS Limited Fundamental Stock Analysis
# Analysis Rating
1 ROE

ROE surpassing expectations (17.4%) highlights strong profitability and efficient use of shareholders' equity, making it an appealing investment prospect.

2 ROA

The stock's ability to make a lot of money from its assets shows that it is very profitable, making it a good choice for people who want to invest and make a lot of money.

3 Dividend

With a solid track record of dividend payments over the past five years, the company has established itself as a dependable choice for investors seeking consistent income.

4 Revenue Growth

Company's revenue has experienced consistent growth over the last three years, indicating a favorable financial trajectory and making it an attractive investment choice.

5 Net Profit Growth

The net profit of this company has shown steady growth over the past three years, highlighting its positive financial trajectory and making it an appealing choice for potential investors.

6 Buffet Intrinsic Value

The company's stock shows potential as it is undervalued (168) according to Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.

7 PBV

The stock's elevated P/BV ratio (5.23x) raises concerns about its overvaluation, making it an imprudent choice for investors seeking value.

8 DER

The stock is burdened with a heavy load of debt (110%), making it financially unstable and potentially risky for investors.

9 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

10 Graham Number

The Graham number of this company suggests that its stock price may be overvalued, indicating a less favorable investment opportunity.

11 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

ALS Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

ALS Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

ALS Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

ALS Limited Revenue
Year Revenue Growth
1988 48.600.000
1989 60.700.000 19.93%
1990 66.600.000 8.86%
1991 0 0%
1992 72.291.000 100%
1993 84.596.000 14.55%
1994 97.133.000 12.91%
1995 113.369.000 14.32%
1996 137.599.008 17.61%
1997 0 0%
1998 200.140.000 100%
1999 271.736.000 26.35%
2000 319.146.000 14.86%
2001 349.696.000 8.74%
2002 359.834.000 2.82%
2003 390.820.000 7.93%
2004 435.595.000 10.28%
2005 522.654.000 16.66%
2006 635.867.000 17.8%
2007 761.030.000 16.45%
2008 920.351.000 17.31%
2009 825.533.000 -11.49%
2010 1.108.329.000 25.52%
2011 1.405.609.000 21.15%
2012 1.455.600.000 3.43%
2013 1.503.400.000 3.18%
2014 1.422.200.000 -5.71%
2015 1.364.900.000 -4.2%
2016 1.272.300.000 -7.28%
2017 1.446.900.000 12.07%
2018 1.664.800.000 13.09%
2019 1.831.900.000 9.12%
2020 1.831.900.000 0%
2020 1.761.400.000 -4%
2021 2.108.500.000 16.46%
2022 2.388.400.000 11.72%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

ALS Limited Research and Development Expenses
Year Research and Development Expenses Growth
1988 0
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 624.000 100%
1999 643.000 2.95%
2000 716.000 10.2%
2001 655.000 -9.31%
2002 0 0%
2003 268.000 100%
2004 41.000 -553.66%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2020 0 0%
2021 0 0%
2022 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

ALS Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
1988 0
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 74.916.000 100%
2002 88.493.000 15.34%
2003 98.988.000 10.6%
2004 118.681.000 16.59%
2005 215.258.000 44.87%
2006 272.169.000 20.91%
2007 355.163.000 23.37%
2008 428.404.000 17.1%
2009 419.785.000 -2.05%
2010 614.915.000 31.73%
2011 749.589.000 17.97%
2012 824.400.000 9.07%
2013 917.600.000 10.16%
2014 975.500.000 5.94%
2015 789.200.000 -23.61%
2016 716.400.000 -10.16%
2017 826.000.000 13.27%
2018 908.100.000 9.04%
2019 1.044.800.000 13.08%
2020 1.044.800.000 0%
2020 986.700.000 -5.89%
2021 1.123.900.000 12.21%
2022 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

ALS Limited EBITDA
Year EBITDA Growth
1988 5.211.000
1989 3.840.000 -35.7%
1990 4.770.000 19.5%
1991 4.635.000 -2.91%
1992 5.461.000 15.13%
1993 6.541.000 16.51%
1994 7.200.000 9.15%
1995 8.433.000 14.62%
1996 13.250.000 36.35%
1997 22.445.000 40.97%
1998 17.986.000 -24.79%
1999 21.587.000 16.68%
2000 24.198.000 10.79%
2001 35.332.000 31.51%
2002 37.963.000 6.93%
2003 43.023.000 11.76%
2004 79.131.000 45.63%
2005 74.044.000 -6.87%
2006 107.270.000 30.97%
2007 147.571.000 27.31%
2008 203.098.000 27.34%
2009 157.121.000 -29.26%
2010 238.048.000 34%
2011 375.287.000 36.57%
2012 403.500.000 6.99%
2013 328.000.000 -23.02%
2014 300.500.000 -9.15%
2015 254.000.000 -18.31%
2016 239.000.000 -6.28%
2017 279.300.000 14.43%
2018 340.800.000 18.05%
2019 414.400.000 17.76%
2020 370.200.000 -11.94%
2020 421.000.000 12.07%
2021 463.200.000 9.11%
2022 579.800.000 20.11%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

ALS Limited Gross Profit
Year Gross Profit Growth
1988 48.600.000
1989 60.700.000 19.93%
1990 66.600.000 8.86%
1991 0 0%
1992 72.291.000 100%
1993 84.596.000 14.55%
1994 97.133.000 12.91%
1995 113.369.000 14.32%
1996 137.599.008 17.61%
1997 0 0%
1998 200.140.000 100%
1999 271.736.000 26.35%
2000 319.146.000 14.86%
2001 186.251.000 -71.35%
2002 195.038.000 4.51%
2003 215.137.000 9.34%
2004 248.889.000 13.56%
2005 313.267.000 20.55%
2006 408.872.000 23.38%
2007 528.303.000 22.61%
2008 669.712.000 21.11%
2009 607.468.000 -10.25%
2010 881.126.000 31.06%
2011 1.167.435.000 24.52%
2012 1.269.900.000 8.07%
2013 1.295.600.000 1.98%
2014 1.305.200.000 0.74%
2015 1.229.000.000 -6.2%
2016 1.144.300.000 -7.4%
2017 1.285.700.000 11%
2018 1.480.700.000 13.17%
2019 1.638.100.000 9.61%
2020 1.638.100.000 0%
2020 1.579.300.000 -3.72%
2021 1.880.700.000 16.03%
2022 626.400.000 -200.24%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

ALS Limited Net Profit
Year Net Profit Growth
1988 0
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 -33.000 100%
1994 -62.000 46.77%
1995 -43.000 -44.19%
1996 1.000 4400%
1997 10.055.000 99.99%
1998 -20.000 50375%
1999 -203.000 90.15%
2000 1.366.000 114.86%
2001 -55.000 2583.64%
2002 361.000 115.24%
2003 35.000 -931.43%
2004 -418.000 108.37%
2005 34.843.000 101.2%
2006 59.066.000 41.01%
2007 76.819.000 23.11%
2008 106.209.000 27.67%
2009 75.301.000 -41.05%
2010 132.354.000 43.11%
2011 222.413.000 40.49%
2012 227.300.000 2.15%
2013 154.400.000 -47.22%
2014 -174.500.000 188.48%
2015 -240.700.000 27.5%
2016 81.600.000 394.98%
2017 51.800.000 -57.53%
2018 153.800.000 66.32%
2019 127.800.000 -20.34%
2020 127.800.000 0%
2020 172.600.000 25.96%
2021 190.500.000 9.4%
2022 294.800.000 35.38%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

ALS Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1988 0
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 1 0%
2012 1 0%
2013 0 0%
2014 0 0%
2015 -1 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2020 0 0%
2021 0 0%
2022 1 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

ALS Limited Free Cashflow
Year Free Cashflow Growth
1988 0
1989 0 0%
1990 0 0%
1991 -1.938.000 100%
1992 2.970.000 165.25%
1993 -1.780.000 266.85%
1994 -13.632.000 86.94%
1995 -1.020.000 -1236.47%
1996 -31.316.000 96.74%
1997 10.829.000 389.19%
1998 4.346.000 -149.17%
1999 -4.855.000 189.52%
2000 -21.640.000 77.56%
2001 -3.914.000 -452.89%
2002 16.534.000 123.67%
2003 13.369.000 -23.67%
2004 12.346.000 -8.29%
2005 19.707.000 37.35%
2006 19.002.000 -3.71%
2007 29.495.000 35.58%
2008 95.197.000 69.02%
2009 56.395.000 -68.8%
2010 88.051.000 35.95%
2011 146.008.000 39.69%
2012 132.800.000 -9.95%
2013 151.300.000 12.23%
2014 138.700.000 -9.08%
2015 95.900.000 -44.63%
2016 116.600.000 17.75%
2017 49.000.000 -137.96%
2018 109.900.000 55.41%
2019 137.900.000 20.3%
2020 184.700.000 25.34%
2021 167.900.000 -10.01%
2022 61.900.000 -171.24%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

ALS Limited Operating Cashflow
Year Operating Cashflow Growth
1988 0
1989 0 0%
1990 0 0%
1991 0 0%
1992 6.058.000 100%
1993 4.113.000 -47.29%
1994 4.651.000 11.57%
1995 7.315.000 36.42%
1996 9.160.000 20.14%
1997 20.606.000 55.55%
1998 10.556.000 -95.21%
1999 14.407.000 26.73%
2000 10.301.000 -39.86%
2001 13.387.000 23.05%
2002 29.127.000 54.04%
2003 25.225.000 -15.47%
2004 30.041.000 16.03%
2005 46.515.000 35.42%
2006 58.096.000 19.93%
2007 79.576.000 26.99%
2008 166.745.000 52.28%
2009 99.565.000 -67.47%
2010 158.842.000 37.32%
2011 228.949.000 30.62%
2012 247.300.000 7.42%
2013 233.900.000 -5.73%
2014 215.200.000 -8.69%
2015 169.600.000 -26.89%
2016 175.300.000 3.25%
2017 122.400.000 -43.22%
2018 218.800.000 44.06%
2019 259.000.000 15.52%
2020 265.800.000 2.56%
2021 286.800.000 7.32%
2022 90.750.000 -216.03%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

ALS Limited Capital Expenditure
Year Capital Expenditure Growth
1988 0
1989 0 0%
1990 0 0%
1991 1.938.000 100%
1992 3.088.000 37.24%
1993 5.893.000 47.6%
1994 18.283.000 67.77%
1995 8.335.000 -119.35%
1996 40.476.000 79.41%
1997 9.777.000 -313.99%
1998 6.210.000 -57.44%
1999 19.262.000 67.76%
2000 31.941.000 39.7%
2001 17.301.000 -84.62%
2002 12.593.000 -37.39%
2003 11.856.000 -6.22%
2004 17.695.000 33%
2005 26.808.000 33.99%
2006 39.094.000 31.43%
2007 50.081.000 21.94%
2008 71.548.000 30%
2009 43.170.000 -65.74%
2010 70.791.000 39.02%
2011 82.941.000 14.65%
2012 114.500.000 27.56%
2013 82.600.000 -38.62%
2014 76.500.000 -7.97%
2015 73.700.000 -3.8%
2016 58.700.000 -25.55%
2017 73.400.000 20.03%
2018 108.900.000 32.6%
2019 121.100.000 10.07%
2020 81.100.000 -49.32%
2021 118.900.000 31.79%
2022 28.850.000 -312.13%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

ALS Limited Equity
Year Equity Growth
1988 13.899.000
1989 18.578.000 25.19%
1990 19.574.000 5.09%
1991 20.635.000 5.14%
1992 28.173.000 26.76%
1993 30.492.000 7.61%
1994 33.922.000 10.11%
1995 46.534.000 27.1%
1996 0 0%
1997 76.721.000 100%
1998 82.404.000 6.9%
1999 88.609.000 7%
2000 100.541.000 11.87%
2001 127.841.000 21.35%
2002 126.491.000 -1.07%
2003 135.746.000 6.82%
2004 151.095.000 10.16%
2005 256.652.000 41.13%
2006 299.547.000 14.32%
2007 338.205.000 11.43%
2008 413.068.000 18.12%
2009 629.744.000 34.41%
2010 825.520.000 23.72%
2011 930.204.000 11.25%
2012 997.100.000 6.71%
2013 1.419.400.000 29.75%
2014 1.228.400.000 -15.55%
2015 1.185.600.000 -3.61%
2016 1.185.200.000 -0.03%
2017 1.122.000.000 -5.63%
2018 1.103.200.000 -1.7%
2019 1.110.600.000 0.67%
2020 1.079.800.000 -2.85%
2021 1.130.700.000 4.5%
2022 1.378.200.000 17.96%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

ALS Limited Assets
Year Assets Growth
1988 26.033.000
1989 38.089.000 31.65%
1990 38.471.000 0.99%
1991 39.315.000 2.15%
1992 45.687.000 13.95%
1993 50.141.000 8.88%
1994 70.015.000 28.39%
1995 75.349.000 7.08%
1996 121.769.000 38.12%
1997 127.224.000 4.29%
1998 139.472.000 8.78%
1999 189.569.000 26.43%
2000 240.484.000 21.17%
2001 271.074.000 11.28%
2002 272.869.000 0.66%
2003 284.345.000 4.04%
2004 302.908.000 6.13%
2005 461.034.000 34.3%
2006 515.929.000 10.64%
2007 677.669.000 23.87%
2008 805.088.000 15.83%
2009 955.085.000 15.71%
2010 1.171.947.000 18.5%
2011 1.635.714.000 28.35%
2012 1.734.700.000 5.71%
2013 2.537.300.000 31.63%
2014 2.406.900.000 -5.42%
2015 2.144.900.000 -12.22%
2016 2.149.600.000 0.22%
2017 2.058.300.000 -4.44%
2018 2.178.700.000 5.53%
2019 2.930.800.000 25.66%
2020 2.476.900.000 -18.33%
2021 2.844.200.000 12.91%
2022 3.330.100.000 14.59%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

ALS Limited Liabilities
Year Liabilities Growth
1988 12.134.000
1989 19.511.000 37.81%
1990 18.897.000 -3.25%
1991 18.680.000 -1.16%
1992 17.514.000 -6.66%
1993 19.649.000 10.87%
1994 36.093.000 45.56%
1995 28.815.000 -25.26%
1996 53.666.000 46.31%
1997 50.503.000 -6.26%
1998 57.068.000 11.5%
1999 100.960.000 43.47%
2000 139.943.000 27.86%
2001 143.233.000 2.3%
2002 146.378.000 2.15%
2003 148.599.000 1.49%
2004 151.813.000 2.12%
2005 204.382.000 25.72%
2006 216.382.000 5.55%
2007 339.464.000 36.26%
2008 392.020.000 13.41%
2009 325.341.000 -20.5%
2010 346.427.000 6.09%
2011 705.510.000 50.9%
2012 737.600.000 4.35%
2013 1.117.900.000 34.02%
2014 1.178.500.000 5.14%
2015 959.300.000 -22.85%
2016 964.400.000 0.53%
2017 936.300.000 -3%
2018 1.075.500.000 12.94%
2019 1.820.200.000 40.91%
2020 1.397.100.000 -30.28%
2021 1.713.500.000 18.47%
2022 1.951.900.000 12.21%

ALS Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
4.71
Net Income per Share
0.6
Price to Earning Ratio
20.71x
Price To Sales Ratio
2.65x
POCF Ratio
13.71
PFCF Ratio
20.55
Price to Book Ratio
4.41
EV to Sales
3.21
EV Over EBITDA
12.45
EV to Operating CashFlow
16.61
EV to FreeCashFlow
24.87
Earnings Yield
0.05
FreeCashFlow Yield
0.05
Market Cap
6,04 Bil.
Enterprise Value
7,31 Bil.
Graham Number
6.19
Graham NetNet
-2.92

Income Statement Metrics

Net Income per Share
0.6
Income Quality
1.51
ROE
0.23
Return On Assets
0.12
Return On Capital Employed
0.26
Net Income per EBT
0.71
EBT Per Ebit
0.83
Ebit per Revenue
0.2
Effective Tax Rate
0.3

Margins

Sales, General, & Administrative to Revenue
0.52
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
-0
Gross Profit Margin
0.2
Operating Profit Margin
0.2
Pretax Profit Margin
0.17
Net Profit Margin
0.12

Dividends

Dividend Yield
0.03
Dividend Yield %
3.13
Payout Ratio
0.61
Dividend Per Share
0.39

Operating Metrics

Operating Cashflow per Share
0.91
Free CashFlow per Share
0.61
Capex to Operating CashFlow
-0.33
Capex to Revenue
-0.06
Capex to Depreciation
-0.96
Return on Invested Capital
0.11
Return on Tangible Assets
0.15
Days Sales Outstanding
66.72
Days Payables Outstanding
145.74
Days of Inventory on Hand
146.61
Receivables Turnover
5.47
Payables Turnover
2.5
Inventory Turnover
2.49
Capex per Share
-0.3

Balance Sheet

Cash per Share
0,37
Book Value per Share
2,83
Tangible Book Value per Share
-0.07
Shareholders Equity per Share
2.83
Interest Debt per Share
3.08
Debt to Equity
1.06
Debt to Assets
0.43
Net Debt to EBITDA
2.16
Current Ratio
1.23
Tangible Asset Value
-0,04 Bil.
Net Current Asset Value
-1,20 Bil.
Invested Capital
1.06
Working Capital
0,14 Bil.
Intangibles to Total Assets
0.42
Average Receivables
0,40 Bil.
Average Payables
0,21 Bil.
Average Inventory
86250000
Debt to Market Cap
0.24

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

ALS Limited Dividends
Year Dividends Growth
1999 0
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 1 0%
2007 1 0%
2008 1 0%
2009 1 0%
2010 1 100%
2011 2 0%
2012 1 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

ALS Limited Profile

About ALS Limited

ALS Limited provides professional technical services primarily in the areas of testing, measurement, and inspection in Africa, Asia/Pacific, Europe, the Middle East, North Africa, and the Americas. The company operates through three segments: Life Sciences, Commodities, and Industrial. The Commodities segment offers assaying and analytical testing, and metallurgical services for the mining and mineral exploration companies in geochemistry, metallurgy, inspection, and coal quality streams. Its testing and consulting services cover the resource life cycle, including exploration, feasibility, optimization, production, design, development, trade, and rehabilitation. This segment also provides coal sampling, analysis and certification, formation evaluation, and related analytical testing services. The Life Sciences segment offers analytical testing and sampling, and remote monitoring services for the environmental, food, pharmaceutical, and consumer products markets; and microbiological, physical, and chemical testing services. This segment also provides analytical testing data to assist consulting and engineering firms, industries, and governments. The Industrial segment offers diagnostic testing and engineering solutions for the energy, resources, transportation, and infrastructure sectors. This segment serves asset owners, operators, constructors, and equipment manufacturers in the power, petrochemical, mining, minerals processing, water, infrastructure, and transportation industries. The company was formerly known as Campbell Brothers Limited and changed its name to ALS Limited in August 2012. ALS Limited was founded in 1863 and is headquartered in Milton, Australia.

CEO
Mr. Malcolm Deane
Employee
19.085
Address
299 Coronation Drive
Milton, 4064

ALS Limited Executives & BODs

ALS Limited Executives & BODs
# Name Age
1 Ms. Heike Truol
Chief Strategy Officer
70
2 Mr. Malcolm Deane
Chief Executive Officer, MD & Director
70
3 Mr. Michael Paul Pearson ACIS, BA, GAICD, L.L.B.
General Counsel & Company Secretary
70
4 Mr. Michael Burcham B Sc, GradDip Env, Grad Cert RM,Grad Dip App, MRAC
Chief Risk Officer
70
5 Mr. Greg Affleck B. Bus (Accounting), CPA
Group Financial Controller
70

ALS Limited Competitors